Viridian Therapeutics Inc.

NASDAQ: VRDN
Share price (12/20/24): $19.03
Market cap (12/20/24): $1.507 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 133 pages Agreement and Plan of Merger Among: Miragen Therapeutics, Inc., a Delaware Corporation; Oculus Merger Sub I, Inc., a Delaware Corporation; Oculus Merger Sub II, LLC, a Delaware Limited Liability Company; and Viridian Therapeutics, Inc., a Delaware Corporation Dated as of October 27, 2020

from S-4 45 pages Subscription Agreement

from 8-K 22 pages Intellectual Property Purchase Agreement

from 425 22 pages Intellectual Property Purchase Agreement

from 8-K 10 pages Support Agreement

from 425 10 pages Support Agreement

from 425 10 pages Support Agreement

from 8-K 10 pages Support Agreement

from 8-K 107 pages Agreement and Plan of Merger and Reorganization Among Signal Genetics, Inc., Signal Merger Sub, Inc., and Miragen Therapeutics, Inc. Dated as of October 31, 2016

from 425 107 pages Agreement and Plan of Merger and Reorganization Among Signal Genetics, Inc., Signal Merger Sub, Inc., and Miragen Therapeutics, Inc. Dated as of October 31, 2016